<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02551315</url>
  </required_header>
  <id_info>
    <org_study_id>EKNZ 2015-117</org_study_id>
    <nct_id>NCT02551315</nct_id>
  </id_info>
  <brief_title>Microarchitecture, Bone Strength and Fracture Risk in Type 2 Diabetes</brief_title>
  <acronym>DiabOS</acronym>
  <official_title>Microarchitecture, Bone Strength and Fracture Risk in Type 2 Diabetes: the DiabOS Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This multicenter, prospective, observational cohort study will assess bone differences in
      women and men with type 2 diabetes mellitus (T2DM) with and without fragility fractures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cross-sectional evaluation of clinical, biochemical and microstructural measures of bone in
      patients with type 2 diabetes and age-matched healthy controls. Longitudinal assessment of
      clinical, biochemical and microstructural measures of bone in study participants without
      prevalent fragility fractures.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Intra-cortical pore volume</measure>
    <time_frame>2 years</time_frame>
    <description>Intracortical pore volume using HR-QCT femoral shaft and mid-tibia and HR-pQCT at the distal radius (mm3)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Areal Bone Mineral Density (aBMD)</measure>
    <time_frame>2 years</time_frame>
    <description>Areal BMD of the spine, the proximal femur and the distal radius (assessed by DXA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bone turnover markers</measure>
    <time_frame>2 years</time_frame>
    <description>alcaline phosphatase, crosslinks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>advanced glycation end products (AGE)</measure>
    <time_frame>2 years</time_frame>
    <description>urinary pentosidine levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurence of fractures during follow up</measure>
    <time_frame>2 years</time_frame>
    <description>incident fracture history</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volumetric Bone Mineral Densitiy (vBMD)</measure>
    <time_frame>2 years</time_frame>
    <description>vBMD of the proximal femur, including trabecular and cortical bone in the femoral neck and Trochanter (assessed by HR-QCT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cortical thickness and porosity</measure>
    <time_frame>2 years</time_frame>
    <description>assessed by HR-QCT at the caudal Region of the femoral neck or the proximal third of the femoral shaft</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">440</enrollment>
  <condition>Type 2 Diabetes Mellitus</condition>
  <condition>Bone Fractures</condition>
  <arm_group>
    <arm_group_label>Type 2 diabetics, no fractures</arm_group_label>
    <description>Postmenopausal women and men with T2DM, without prevalent fragility fractures (longitudinal follow-up)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 2 diabetics, prevalent fractures</arm_group_label>
    <description>Postmenopausal women and men with T2DM, with prevalent fragility fractures</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls, no fractures</arm_group_label>
    <description>Age and sex-matched non-diabetic controls, without fragility fractures (longitudinal follow-up)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls, prevalent fractures</arm_group_label>
    <description>Age and sex-matched non-diabetic controls</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bone trunover markers, parameters re calcium metabolism, HbA1c, Insulin, pentosidine, markers
      of inflammation
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Female and male diabetics (aged between 50 and 75 years; BMI between 18 and 37 kg/m2) Age-
        and sex-matched non-diabetic controls
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - presence of type 2 diabetes for at least 3 years (history of treatment for type 2
        diabetes)

        Exclusion Criteria:

          -  immobility

          -  coexisting metabolic bone disease or comorbidities affecting bone health

          -  previous treatment with osteoporosis medication or intake of medications known to
             affect bone metabolism (e.g. steroids) within 6 months prior to enrolment

          -  thiazolidinedione use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Meier, Prof. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Meier, Prof. MD</last_name>
    <phone>+41 (0)61 264 97 97</phone>
    <email>christian.meier@unibas.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Janina Vavanikunnel, MD</last_name>
    <phone>+41 (0)61 265 50 78</phone>
    <email>janina.vavanikunnel@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Department of Internal Medicine, University Basel, Kantonsspital</name>
      <address>
        <city>Aarau</city>
        <state>AG</state>
        <zip>5001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Beat Müller, Prof. MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Anne Katrin Borm, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine, Kantonsspital Bruderholz</name>
      <address>
        <city>Binningen</city>
        <state>BL</state>
        <zip>4101</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Felix, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Internal Medicine, Kantonsspital Luzern</name>
      <address>
        <city>Luzern</city>
        <state>LU</state>
        <zip>6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Henzen, PD MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Department of Medicine, St. Anna Hospital Hirslanden</name>
      <address>
        <city>Luzern</city>
        <state>LU</state>
        <zip>6006</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Reto Krapf, Prof. MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Division of Endocrinology, Diabetology and Metabolism, University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janina Vavanikunnel, MD</last_name>
      <phone>+41(0)61 265 50 78</phone>
      <email>janina.vavanikunnel@usb.ch</email>
    </contact>
    <contact_backup>
      <last_name>Christian Meier, Prof. MD</last_name>
      <phone>+41(0)61 264 97 97</phone>
      <email>christian.meier@unibas.ch</email>
    </contact_backup>
    <investigator>
      <last_name>Marc Donath, Prof. MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marius Kränzlin, Prof. MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Norbert Suhm, Prof. MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2015</study_first_submitted>
  <study_first_submitted_qc>September 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2015</study_first_posted>
  <last_update_submitted>November 19, 2017</last_update_submitted>
  <last_update_submitted_qc>November 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Basel, Switzerland</investigator_affiliation>
    <investigator_full_name>Christian Meier</investigator_full_name>
    <investigator_title>Prof. Dr. med.</investigator_title>
  </responsible_party>
  <keyword>Intra-cortical pore volume</keyword>
  <keyword>HR-pQCT</keyword>
  <keyword>DXA</keyword>
  <keyword>bone mineral density</keyword>
  <keyword>bone turnover markers</keyword>
  <keyword>urinary pentosidine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

